ASCO 2025: Retrospective validation of a novel multimodal AI prognostic tool integrating digital pathology and clinical data against real world data and Oncotype DX in a Swiss breast cancer cohort.
Empowering physicians with advanced multi-modal tools to improve treatment selection and patient outcomes.
Back To Top